Dow Up 0.05% Nasdaq Down 0.18%

More On CYCCP

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

Cyclacel Pharmaceuticals, Inc. (CYCCP)

-NasdaqCM
4.82 Up 0.22(4.78%) 9:30AM EDT
Prev Close:4.60
Open:4.82
Bid:4.60 x 100
Ask:6.55 x 500
1y Target Est:N/A
Beta:1.08263
Next Earnings Date:N/A
Day's Range:4.82 - 4.82
52wk Range:3.60 - 7.77
Volume:260
Avg Vol (3m):310
Market Cap:167.26M
P/E (ttm):N/A
EPS (ttm):-0.54
Div & Yield:0.60 (14.25%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):90.19
Ex-Dividend Date:19-Jan-16

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs for the treatment of cancer and other diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback